PR Newswire TechnologyCodex · 实盘不做把握 8/10
北京时间·🕒 发布 04:30:00时区推断·⟳ 抓取 04:33:28·⚡ 决策 07-11 04:34:41 +1m13s·108.8 天前
Vanda Pharmaceuticals 将参加券商炉边谈话会议
这只是公司参加 B. Riley Securities 投资者会议的日程公告，没有披露新药进展、监管批准、订单、业绩或资本动作。
📄 原文PR Newswire Technology↗ 原文
WASHINGTON, July 10, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the co…
不做 Vanda Pharmaceuticals（VNDA.US）
例行投资者会议参与公告，没有明确利多/利空方向，也没有收入、利润、监管或产品进展增量，无法形成正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-10 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是公司参加 B. Riley Securities 投资者会议的日程公告，没有披露新药进展、监管批准、订单、业绩或资本动作。
主要风险
- 若会议当天另行披露实质性临床、商业化或战略信息，需要按新信号重新评估。
原文全文
展开原文 · 866 字
WASHINGTON, July 10, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
SOURCE Vanda Pharmaceuticals Inc.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
SOURCE Vanda Pharmaceuticals Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。